Elite in Prostate Cancer

Frederik L. Giesel

Bonn, NW, DE 
Elite in Prostate Cancer
Bonn, NW, DE 
OverviewLocationsClinical Research

Overview

Frederik Giesel practices in Bonn, Germany. Mr. Giesel is rated as an Elite expert by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Neuroendocrine Tumor, Meningioma, Dry Mouth, and Prostatectomy.

His clinical research consists of co-authoring 292 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 103 articles and participated in 1 clinical trial in the study of Prostate Cancer.

Gender
Male

Locations

Bonn, NW 53127, Germany
Other Locations
Duesseldorf, NW, Germany
Aachen, NW, Germany
Heine, NW, Germany
Heidelberg, BW, Germany
Dresden, SN 01328, Germany
Berlin, BE 12489, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-label, Single-arm, Rater-blinded, Multicenter Phase 1/2 Study to Assess Safety and Diagnostic Accuracy and Radiotherapeutic Implications of Pre-operative Ga-68-PSMA-11 PET/CT Imaging in Comparison to Histopathology, in Newly-diagnosed Prostate Cancer (PCA) Patients at High Risk for Metastasis, Scheduled for Radical Prostatectomy (RP) With Extended Pelvic Lymph Node Dissection (EPLND)
An Open-label, Single-arm, Rater-blinded, Multicenter Phase 1/2 Study to Assess Safety and Diagnostic Accuracy and Radiotherapeutic Implications of Pre-operative Ga-68-PSMA-11 PET/CT Imaging in Comparison to Histopathology, in Newly-diagnosed Prostate Cancer (PCA) Patients at High Risk for Metastasis, Scheduled for Radical Prostatectomy (RP) With Extended Pelvic Lymph Node Dissection (EPLND)
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

292 Total Publications

Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5.
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5.
Journal: Seminars in nuclear medicine
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Giesel's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile